Post Subject #220531   0 This one has a ton of Catalyst coming matt24d 08/17/18 04:02:31 PM #220530   0 Does anyone have an opinion on ADMA? I ronpopeil 08/17/18 02:11:42 PM #220529   0 Both companies—(GILD and ABBV)—have said that US HCV DewDiligence 08/17/18 12:45:23 PM #220528   0 While the 51.7% versus 47.4% is pretty close jbog 08/17/18 12:43:05 PM #220527   0 Mavyret’s US new-patient share=51.7%—the highest-ever weekly figure—in th DewDiligence 08/17/18 11:45:04 AM #220526   0 This story broke one month ago—see #msg-142324338. DewDiligence 08/17/18 11:41:43 AM #220525   0 FDA approves Opdivo monothearpy for third-line SCLC—the first DewDiligence 08/17/18 11:38:52 AM #220524   0 EOLS—Apparently, Health Canada was more forgiving on CMC DewDiligence 08/17/18 11:32:07 AM #220523   0 Good question. EPVantage omitted RT002 in their 2017 DewDiligence 08/17/18 11:30:25 AM #220522   0 EOLS gets approval in Canada xavierprivas 08/17/18 08:42:09 AM #220521   0 Louisiana seeking comments on 'Netflix' model for hepatitis jbog 08/16/18 10:39:11 PM #220520   0 Yes, absolutely. Bickema 08/16/18 10:06:20 PM #220519   0 Thanks! (eom) DewDiligence 08/16/18 04:50:07 PM #220518   0 It's LenviMa ciotera 08/16/18 04:43:53 PM #220517   0 MRK/Eisai—FDA approves Lenvina monothearpy in first-line HCC: DewDiligence 08/16/18 04:23:01 PM #220516   0 Yes, absolutely. DewDiligence 08/16/18 03:56:47 PM #220515   0 https://endpts.com/gilead-loses-key-patent-claims-for-sovaldi-in-china-opening-d caravon 08/16/18 03:48:50 PM #220514   0 More news re TEVA: north40000 08/16/18 03:08:07 PM #220513   0 Would you add RT002 to that list? Bickema 08/16/18 01:02:17 PM #220512   0 TEVA+4%/REGN+2% on Fasinumab nominally-positive phase-3 data in OA: DewDiligence 08/16/18 11:53:59 AM #220511   0 PTIE -50% on $11M direct offering https://twitter.com/mychartcoachcom/status/10 Titan V 08/16/18 10:54:35 AM #220510   0 SBBP rescinds offering after 19% sell-off: DewDiligence 08/15/18 09:30:30 PM #220509   0 Agreed! (eom) Titan V 08/15/18 03:25:53 PM #220508   0 That list is based on a consensus of DewDiligence 08/15/18 02:20:17 PM #220507   0 Most valuable unpartnered assets reveal a changing of Titan V 08/15/18 02:17:27 PM #220506   0 Gilead loses key patent claims for Sovaldi in caravon 08/15/18 12:57:41 PM #220505   0 Biotech Jim. Re the following in Whalatane 08/15/18 12:48:21 PM #220504   0 EOLS makes CMO head of R&D—IOW, EOLS doesn’t DewDiligence 08/15/18 11:32:40 AM #220503   0 Reuters on GSK/JNJ’s Cabotegravir/Edurant prospects: DewDiligence 08/15/18 11:27:10 AM #220502   0 GILD – Chief Medical Officer, Andrew Cheng, MD, biotech_researcher 08/15/18 09:21:38 AM #220501   0 Re: OMER biotech jim 08/15/18 08:56:11 AM #220500   0 I think the biggest disruptive potential is with dewophile 08/15/18 08:34:17 AM #220499   0 As to TA and chart action of OMER, biotech jim 08/15/18 08:12:37 AM #220498   0 ATNM - News awaited traderin 08/15/18 05:46:57 AM #220497   0 OMER down. BiotechJim What'd you expect from chart/data? Biowatch 08/14/18 09:18:11 PM #220496   0 To an homologous regime. Here is other preclinical jondoeuk 08/14/18 02:10:19 PM #220495   0 Gritstone—...This has been shown to induce greater numbers DewDiligence 08/14/18 01:34:02 PM #220494   0 Gritstone will be using a heterologous prime-boost regime. jondoeuk 08/14/18 01:27:35 PM #220493   0 BLUSF continuing to look very strong. May have ronpopeil 08/14/18 11:47:41 AM #220492   0 RLM.L -50% on phase-2 failure: DewDiligence 08/14/18 10:51:25 AM #220491   0 CCXI was downgraded by JPM: DewDiligence 08/14/18 10:43:36 AM #220490   0 ARDS IPOs 2.30M* shares @$13.00—low-end of anticipated range: DewDiligence 08/14/18 10:41:20 AM #220489   0 CCXI reports 2nd quarter results. Stock down 13% bladerunner1717 08/14/18 10:27:46 AM #220488   0 ENTA’s current tax rate—excluding discrete items—is ~18%. DewDiligence 08/13/18 07:40:59 PM #220487   0 Re: HCV in China Mayvret is not DewDiligence 08/13/18 11:08:59 AM #220486   0 I was referring to clinical data analysis....sorry I n4807g 08/13/18 04:22:12 AM #220485   0 Only 1 biotech company is debuting on the traderin 08/13/18 01:13:09 AM #220484   0 Ok, Thanks. The article made it sound like DaveAu 08/12/18 10:01:07 PM #220482   0 Guessing from the chart, it'll go down again Biowatch 08/12/18 09:07:27 PM #220480   0 How much can companies charge now for whatever DewDiligence 08/12/18 08:59:33 PM Post Subject

© 2018 InvestorsHub.com, Inc.